Title:
COMPOSITION FOR INHIBITING CYTOTOXIC ANTICANCER DRUG SIDE-EFFECTS USING GINSENOSIDE COMPOUND K
Document Type and Number:
WIPO Patent Application WO/2018/131963
Kind Code:
A1
Abstract:
Disclosed is an effect of ginsenoside compound K for inhibiting cytotoxic anticancer drug side-effects such as gastrointestinal disorders, bone marrow dysfunction, liver, kidney, and pancreatic dysfunction and the like.
Inventors:
CHUNG HONG KEUN (KR)
HAN BYUNG YOUL (KR)
LEE SUN YOUNG (KR)
HAM SEUNG HEE (KR)
HAN BYUNG YOUL (KR)
LEE SUN YOUNG (KR)
HAM SEUNG HEE (KR)
Application Number:
PCT/KR2018/000669
Publication Date:
July 19, 2018
Filing Date:
January 15, 2018
Export Citation:
Assignee:
MGINBIO CO LTD (KR)
International Classes:
A61K31/704; A23L33/10; A61K45/06
Foreign References:
| KR20160137808A | 2016-12-01 | |||
| KR20040087407A | 2004-10-14 | |||
| KR20160112094A | 2016-09-28 | |||
| KR20090058366A | 2009-06-09 | |||
| KR100992800B1 | 2010-11-08 |
Attorney, Agent or Firm:
TW INTERNATIONAL PATENT AND LAW FIRM (KR)
Download PDF:
Previous Patent: CARRIER-FOIL-ATTACHED ULTRA-THIN COPPER FOIL
Next Patent: CARRIER-FOIL-ATTACHED ULTRA-THIN COPPER FOIL
Next Patent: CARRIER-FOIL-ATTACHED ULTRA-THIN COPPER FOIL